Unlocking the power
of lymphatic medicine
Over the past decade, there has been an explosion of research uncovering the critical role the lymphatic system plays in serious diseases affecting more than 500 million people globally. The opportunity to address this need is immense, and Ropirio is at the forefront, having identified the first target that activates the lymphatic system. This activation improves lymphatic flow, modulates inflammation, and prevents fibrosis. Ropirio is singularly focused on developing the first lymphatic medicines to improve patients’ lives.
We are a team of visionaries with deep experience in company building, dedicated to researching and developing novel medicines that push the power of the lymphatic system beyond what was previously thought possible.
The power of the right team
CHIEF EXECUTIVE OFFICER
FOUNDER, DIRECTOR
FOUNDER, DIRECTOR
FOUNDER, HEAD OF
NON-CLINICAL DEVELOPMENT
FOUNDER, EXECUTIVE CHAIR
DIRECTOR, STRATEGIC ADVISOR
DIRECTOR
DIRECTOR
SCIENTIFIC ADVISOR
SCIENTIFIC ADVISOR